<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-4738</issn>
      <issn pub-type="epub">1998-3689</issn>
      <publisher>
        <publisher-name>Medknow Publications</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18158419</article-id>
      <article-id pub-id-type="pmc">2636059</article-id>
      <article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_1_84_37586</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Trans-pupillary thermotherapy for circumscribed choroidal hemangioma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Rishi</surname>
            <given-names>Pukhraj</given-names>
          </name>
          <degrees>MS</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>Tarun</given-names>
          </name>
          <degrees>MS, FRCSEd</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chhablani</surname>
            <given-names>Jay</given-names>
          </name>
          <degrees>MS</degrees>
        </contrib>
        <aff>Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralya, 18 College Road, Chennai - 600 006	, India. E-mail: <email>docrishi@yahoo.co.in</email></aff>
      </contrib-group>
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2008</year>
      </pub-date>
      <volume>56</volume>
      <issue>1</issue>
      <fpage>84</fpage>
      <lpage>85</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Ophthalmology</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>We read the article by Shukla <italic>et al</italic>.<xref ref-type="bibr" rid="ref1">1</xref> on  &#x2033;Vitrectomy for
circumscribed choroidal hemangioma (CCH) with exudative
retinal detachment refractory to transpupillary thermotherapy
(TTT)&#x2033; with interest. We would like to share our experience
about a similar case.</p>
    <p>We have reported a case of a 13-year-old girl with a large,
subfoveal CCH and a total, secondary retinal detachment [<xref ref-type="fig" rid="F1">Fig.
1</xref>].<xref ref-type="bibr" rid="ref2">2</xref> The tumor measured 6.0 mm in height with a base of 14.2 mm
x 13.8 mm. At presentation, visual acuity was reduced to bare
perception of light. The patient underwent three applications
of TTT at zero, five and 10 weeks. At six months after the first
session of TTT, the retina was totally re-attached; vision improved
to 7/200. The retina remained attached at the last follow-up, three
years from presentation with visual acuity improving to 20/40,
N6. It is noteworthy that the subfoveal area of the tumor was not
directly treated, hence allowing good visual recovery even while
successfully arresting the tumor activity [<xref ref-type="fig" rid="F2">Fig. 2</xref>].</p>
    <p>Garcia-Arumi <italic>et al</italic>.<xref ref-type="bibr" rid="ref3">3</xref> also showed that most of the tumors
(62.5%) required two or three applications of TTT to obtain
occlusion of the tumor vessels. The end point of TTT in treatment
of CCH is the resolution of exudative retinal detachment at the
fovea and not total tumor destruction. If the subretinal fluid
fails to resolve after one treatment, second and third treatment
sessions can be applied. Further treatment is not necessary if
the exudation from the tumor stops. In the case reported by
Shukla <italic>et al</italic>.<xref ref-type="bibr" rid="ref1">1</xref> TTT was applied only once and then presumed
to be refractory to further treatment. Also, it would have been
worthwhile to mention the tumor dimensions.</p>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shukla</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ramasamy</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Vitrectomy for circumscribed choroidal hemangioma with exudative retinal detachment refractory to transpupillary thermotherapy</article-title>
          <source>Indian J Ophthalmol</source>
          <year>2007</year>
          <volume>55</volume>
          <fpage>298</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17595480</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rishi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Transpupillary thermotherapy for large-sized subfoveal circumscribed choroidal hemangioma</article-title>
          <source>Retina</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>974</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">17031306</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Arumi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Guraya</surname>
              <given-names>BC</given-names>
            </name>
          </person-group>
          <article-title>Transpupillary thermotherapy for circumscribed choroidal hemangioma</article-title>
          <source>Ophthlmology</source>
          <year>2000</year>
          <volume>107</volume>
          <fpage>351</fpage>
          <lpage>7</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>At presentation, right eye fundus reveals a large orangered, well-delineated, subretinal mass lesion at the fovea suggestive of circumscribed choroidal hemangioma. Exudative retinal detachment involves the fovea</p>
      </caption>
      <alt-text>Figure 1</alt-text>
      <graphic xlink:href="IndianJOphthalmol-56-84-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>At 18 months follow-up, the tumor has regressed with complete resorption of subretinal fluid and visual improvement</p>
      </caption>
      <alt-text>Figure 2</alt-text>
      <graphic xlink:href="IndianJOphthalmol-56-84-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
